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The oxygen-dependent parameter that is perceived by the oxygen sensor is likely to be influenced not only by renal oxygen supply but also, in an inverse fashion, by renal oxygen consumption. The predominant determinant of renal oxygen consumption is tubular sodium reabsorption (3, 13, 17, 24) . However, a direct relationship between EPO production and tubular oxygen consumption has not yet been established. Recently it has been shown that the cells producing EPO are not part of the renal tubule itself, but are located in the renal interstitium (14, 16). The question arises therefore, whether or not the regulation of EPO production is at all related to tubular function. In addition, if such a relationship between tubular function and EPO production exists, it seems essential for the understanding of the renal oxygen sensor to define the part of the nephron involved in the regulation of EPO production.
To investigate this question, we used diuretic drugs with predominant sites of action at different segments of the nephron to inhibit sodium reabsorption and therewith reduce tubular oxygen consumption. We studied the effect of this intervention on the hypoxia-induced EPO response in mice. The influence of different diuretics on EPO production has to our knowledge so far only been investigated by Fisher et al. (8) in 1963 . However, these investigators chose an entirely different approach, as they used cobalt as stimulus for EPO formation. Indirect evidence for a role of tubular work in the regulation of EPO production was previously provided by . They have demonstrated an inhibitory effect of acetazolamide on EPO production in humans exposed to simulated altitude. However, in their study a potential effect of acetazolamide on sodium reabsorption and renal oxygen consumption was not considered. The authors attributed the inhibitory effect of acetazolamide to prevention of the respiratory alkalosis normally occurring under hypoxia and an associated rightward shift of the oxygen dissociation curve, finally resulting in an increased peripheral tissue <oxygenation.
Employing four different diuretics, our results show that furosemide, hydrochlorothiazide, and amiloride, which are considered to mainly effect sodium transport in the loop of Henle, the distal tubule, and collecting duct, respectively, do not impair the hypoxia-induced EPO production. On the other hand, acetazolamide that is thought to preferentially act at the proximal tubular site, significantly reduced EPO formation in close correlation to the natriuresis induced and independent from changes in systemic acid base status.
MATERIALS AND METHODS
Male Institute of Cancer Research (ICR) strain mice (body wt 25-32 g) were used in this study. in the polycythemic mouse bioassay (4) and used as standard in the RIA (Fig. 1) .
Determination of standard bicarbonate concentrations. Animals were anesthetized with 500 mg/kg body wt 5-ethyl-5-(1'-methylpropyl)-2-thiobarbituric acid (Inactin, Byk-Gulden, Constance, FRG) injected intraperitoneally in a concentration of 100 mg/ml. Immediately after onset of anesthesia they were bled from the retro-orbital sinus into heparinized glass capillary tubes that were then instantly transferred to a computerized blood gas analyzer (IL 1304, Instrumentation Laboratory, Lexington, MA).
Statistics. Levels of significance were calculated by use of Student's t test. P < 0.05 was considered significant.
RESULTS
Kinetics of hypoxia-induced EPO response. Figure 2 shows the kinetics of serum EPO levels in response normobaric hypoxia (7% 02) and functional anemia to induced by carbon monoxide inhalation (0.1% CO). Consistent with previous investigations (2, 20) serum EPO levels began to rise l-2 h after the onset of the hypoxic stimulus. Independent of the degree of stimulation a linear increase of serum EPO levels was observed after 3 h of hypoxia and this time point was therefore selected for further experiments. Effect of diuretics on sodium excretion and urine volume. Acetazolamide, furosemide, hydrochlorothiazide, and amiloride were used to inhibit sodium reabsorption predominantly site specific in the proximal tubule, the thick ascending limb of the loop of Henle, the early distal tubule, and the late distal tubule and collecting duct, respectively. To assess the degree of inhibition of sodium reabsorption, the effects of the diuretics on urine volume and sodium excretion were measured and the results are given in Table 1 . All four drugs led to significant diuresis and natriuresis. To assess a possible underestimation of the effectiveness of acetazolamide caused by compensatory sodium reabsorption in the more distal parts of the nephron, the natriuretic effect of a low dose (25 mg/kg) of acetazolamide was also tested in the presence of furosemide and hydrochlorothiazide.
However, under these conditions the acetazolamide-induced increase in natriuresis was not different from the natriuresis brought about by acetazolamide alone (41 pmol vs. 40 pmol Na per animal within 3 h).
Effect of diuretics on EPO production. To test any direct stimulatory effect of the diuretics on EPO production, which might have compensated a possible reduction of hypoxia-induced EPO formation, EPO levels were measured in normoxic animals after application of diuretics for 3 h. With acetazolamide (25 or 500 mg/kg), hydrochlorothiazide and amiloride EPO levels did not change significantly (data not shown), whereas with furosemide we observed an increase from 29.5 t 3 to 55.2 t 12 mu/ml (mean t SE, n = 10; P c 0.005).
To study the effect of diuretics on hypoxia-induced EPO formation, hypoxic stimuli of three different degrees, including two degrees of normobaric arterial hypoxia as well as carbon monoxide inhalation were used. The results obtained with carbon monoxide inhalation (0.1%) are shown in Fig. 3 . With furosemide, hydrochlorothiazide, and amiloride we found no alteration of the hypoxia-induced EPO response compared with control animals injected with the vehicle only. Also the combined application of furosemide and hydrochlorothiazide did not influence EPO formation. With acetazolamide (500 mg/kg), however, there was a significant reduction of the EPO response (P < 0.001).
A similar inhibitory effect of acetazolamide on EPO production was observed in response to both degrees of arterial hypoxia (8% 02 and 14% 02). (Fig. 4, left) . In contrast, furosemide and hydrochlorothiazide, either alone or in combination, and amiloride did not reduce the EPO response (Table 2 ). With furosemide there was even a slight, but significant increase in response to both stimuli.
Figure 4 (right) shows that the inhibitory effect of acetazolamide on EPO production in response to normobaric hypoxia (8% 02) was dose dependent; whereas 25 and 100 mg/kg did not change EPO production significantly, EPO levels were significantly reduced after administration of 200 and 500 mg/kg (P c 0.025 and P < 0.001, respectively). In contrast the effect of acetazolamide on acid-base status of the animals was not dose dependent over the same range of concentrations, as demonstrated in Fig. 5 , top. Both 25 and 500 mg/kg body wt led to a significant reduction of sodium bicarbonate concentrations (P c 0.01) that was, however, not differ- ent between the two doses. Furthermore, simultaneous application of sodium bicarbonate together with acetazolamide, which restored standard bicarbonate levels to at least normal concentrations (Fig. 5, top) , did not diminish the inhibitory effect of acetazolamide on EPO production in response to hypoxia (8% 02) (Fig. 5, bottom) . Sodium bicarbonate per se did not significantly alter the hypoxia-induced EPO formation (Fig. 5 , bottom). Figure 6 demonstrates that the inhibitory effect of acetazolamide on EPO production paralleled the natriuresis brought about with the different doses of the drug.
DISCUSSION
This study was aimed at investigating the effect of inhibition of tubular sodium reabsorption in different parts of the nephron on the hypoxia-induced renal EPO formation. To this end we used diuretic drugs that are known to block sodium reabsorption preferentially in the proximal tubule (acetazolamide), the thick ascending limb of the loop of Henle (furosemide), the early distal tubule (hydrochlorothiazide), and the late distal tubule and collecting duct (amiloride) (12, 21) . We explicitly assume that an inhibition of sodium reabsorption is associated with a decrease in tubular oxvgen consump- response to normobaric arterial hypoxia (8% 02) (right) (means k SE, n = 10-20). EPO levels under acetazolamide were significantly different from untreated controls with 100 a dose of 500 mg/kg at 8% (P < 0.001) and 14% 02 (P < 0.001) and with a dose of 200 mg/kg at 8% 02 (P < 0.025).
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NakO, (20mmoVkg) FIG. 5. Effect of acetazolamide (AC; 25 or 500 mg/kg), sodium bicarbonate (NaHCO,; 20 mmol/kg) and combined application of AC and NaHC03 (20 mmol/kg) on standard bicarbonate concentrations (top) and erythropoietin (EPO) formation in response to 8% 02 (bottom). *P < 0.025; **P < 0.01; *** P < 0.005; O P < 0.001 vs. controls.
tion. This assumption is supported by a number of experiments in which a positive and linear relationship was established between the amount of sodium reabsorbed and renal oxygen consumption (3, 13, 17, 24) .
Interpretation of the effect of the diuretics used in the present study on EPO formation requires an estimate of the efficacy with which sodium reabsorption was blocked at the respective segments of the nephron. Such an estimate can be made on the basis of the data on sodium excretion in controls and in animals receiving diuretics ( Table 1 ). Assuming that sodium excretion of control animals corresponds to 1% of their filtered sodium load, an approximate calculation of fractional sodium excretion under the different diuretics can be computed by relating the absolute sodium excretion of animals with diuretic treatment to that of controls (Table 3, 
top half).
A comparison of these figures with the fraction of sodium normally reabsorbed at the different parts of the nephron (11, 21) (Table 3 , bottom halfi reveals that with amiloride, hydrochlorothiazide, and furosemide in the doses used, sodium reabsorption was intensively blocked in the collecting duct, distal tubule, and thick ascending limb of the loop of Henle.
Nevertheless, the EPO response to mild and severe hypoxia was not reduced under each of these three diuretics (Table 2, Fig. 3 ). Also the combined application of furosemide and hydrochlorothiazide did not blunt the EPO response, thus excluding the possibility of masking a potential effect of furosemide on EPO production by a compensatory increase of distal tubular reabsorption rate. How furosemide led to a slight increase of basal as well as stimulated EPO levels in response to arterial hypoxia (Table 2 ) cannot be explained on the basis of the present investigation. However, furosemide is known to increase renal prostaglandin formation (1, 26) , and prostaglandins have been shown to stimulate EPO production (7).
In contrast to the results obtained with diuretics acting in the loop of Henle and more distal parts of the nephron, we found a significant reduction of hypoxia-induced EPO formation after administration of acetazolamide, a diuretic that is considered to act predominantly at the proximal tubular site (12, 21) , using a dose of 200 or 500 mg/kg (Figs. 3 and 4) . It should be noted that doses of acetazolamide given to humans are severalfold lower on a dose per kilogram body weight basis. However, natriuresis achieved with the low doses used in clinical routine usually does not exceed 5% of the filtered sodium load (12). In contrast, with the dosage of 500 mg acetazolamide/kg, up to which a linear log dose-response relationship has previously been established for the drug (18), fractional sodium excretion corresponded to approximately one-third of normal proximal tubular sodium reabsorption (Table 3) . Two established effects of acetazolamide are likely to reduce the oxygen demand of the proximal tubule. First, the drug directly interferes with reabsorptive function by inhibiting carbonic anhydrase and second, it diminishes reabsorption rate indirectly by reducing the filtered solute load via activation of the tubuloglomerular feedback system (12, 21) . At the same time urinary bicarbonate loss leads to a reduction in plasma bicarbonate concentrations.
Miller and coworkers (19)) who previously demonstrated an inhibitory effect of acetazolamide on EPO production in humans, attributed this effect to changes in the acid base status. The authors concluded that acetazolamide treatment prevented the respiratory alkalosis, normally occurring under hypoxic conditions, and thereby prevented a leftward shift in the oxygen dissociation curve, finally resulting in an increased peripheral tissue oxygenation. These investigators did not consider a potential effect of acetazolamide on sodium reabsorption. However, it has been demonstrated that a comparable dose of acetazolamide administered to humans causes a 30% rise in lithium clearance (23), thus indicating a considerable inhibition of proximal tubular sodium reabsorption. To further distinguish the possible mechanism by which the reduction in EPO response could have been mediated in our experiments, we intended to compensate for the metabolic acidosis, but not the natriuretic effect of the drug, by simultaneous treatment with acetazolamide and high doses of sodium bicarbonate. This regime resulted in normal or even slightly enhanced standard bicarbonate concentrations (Fig. 5, top) . Nevertheless, the inhibitory effect of acetazolamide was not diminished by the simultaneous application of sodium bicarbonate (Fig. 5,  bottom) . Furthermore, the metabolic acidosis with low 
